We are live on
!
Find out more
CAG
Crestwood Advisors Group Portfolio holdings
AUM
$5.94B
1-Year Est. Return
18.44%
This Fund
S&P 500
This Quarter
Est. Return
+2.6%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$809M
AUM Growth
-$38.3M
(-4.5%)
Cap. Flow
-$53.5M
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
32.36%
Holding
146
New
7
Increased
49
Reduced
46
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$10.8M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.92M |
| 3 |
Cisco
CSCO
|
+$1.28M |
| 4 |
Microsoft
MSFT
|
+$1.06M |
| 5 |
PCH
PotlatchDeltic
PCH
|
+$899K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$21.5M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$17.2M |
| 3 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$15M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$5.6M |
| 5 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$4.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.13% |
| 2 | Healthcare | 13.32% |
| 3 | Technology | 10.85% |
| 4 | Consumer Staples | 9.63% |
| 5 | Consumer Discretionary | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Russell 2000 ETF
IWM
$81.6B
| $333K | 0.04% |
2,894
+725
| +33% | +$81.8K |
|
|
CELG
102
DELISTED
Celgene Corp
CELG
| $326K | 0.04% |
3,301
-350
| -10% | -$36.2K |
|
103
Costco
COST
$415B
| $315K | 0.04% |
2,003
-157
| -7% | -$23.8K |
|
104
Intel
INTC
$495B
| $308K | 0.04% |
9,391
+2,862
| +44% | +$89.7K |
|
|
SRCL
105
DELISTED
Stericycle Inc
SRCL
| $297K | 0.04% |
2,850
| – | – |
|
106
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $289K | 0.04% |
1,380
+402
| +41% | +$83.4K |
|
107
AbbVie
ABBV
$448B
| $287K | 0.04% |
4,632
+230
| +5% | +$14K |
|
108
Boston Scientific
BSX
$65.8B
| $287K | 0.04% |
12,294
-4,050
| -25% | -$87.6K |
|
109
Cimpress
CMPR
$2.48B
| $277K | 0.03% |
2,994
| – | – |
|
110
JPMorgan Chase
JPM
$902B
| $270K | 0.03% |
4,339
-650
| -13% | -$40.6K |
|
111
iShares MSCI KLD 400 Social ETF
DSI
$5.27B
| $263K | 0.03% |
6,800
| – | – |
|
112
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
| $259K | 0.03% |
5,990
| – | – |
|
113
Salesforce
CRM
$143B
| $258K | 0.03% |
+3,255
| New | +$255K |
|
|
RDS.A
114
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $257K | 0.03% |
4,650
| – | – |
|
115
Caterpillar
CAT
$399B
| $256K | 0.03% |
3,380
| – | – |
|
116
Norfolk Southern
NSC
$75.5B
| $255K | 0.03% |
3,000
| – | – |
|
117
Ball Corp
BALL
$16.5B
| $253K | 0.03% |
7,000
| – | – |
|
118
Eversource Energy
ES
$27.8B
| $240K | 0.03% |
4,000
| – | – |
|
119
Ford
F
$55.9B
| $239K | 0.03% |
19,000
| – | – |
|
|
UN
120
DELISTED
Unilever NV New York Registry Shares
UN
| $238K | 0.03% |
5,077
| – | – |
|
121
Schwab US Broad Market ETF
SCHB
$43.1B
| $234K | 0.03% |
27,900
+1,860
| +7% | +$15.4K |
|
122
US Bancorp
USB
$98.5B
| $233K | 0.03% |
5,770
-175
| -3% | -$7.28K |
|
123
Northrop Grumman
NOC
$75.6B
| $223K | 0.03% |
+1,003
| New | +$211K |
|
124
Vanguard S&P 500 ETF
VOO
$976B
| $218K | 0.03% |
+1,136
| New | +$216K |
|
125
Qualcomm
QCOM
$181B
| $214K | 0.03% |
4,000
| – | – |
|
Similar funds
AL
CGPCS
BP
BTCPP
WAM
GFM
VAM
TCM
Crestwood Advisors Group's Q2 2016 Portfolio in Review
As of Q2 2016, Crestwood Advisors Group held 146 positions worth $809M, down 4.5% from $848M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Crestwood Advisors Group withdrew a net $53.5M in Q2 2016, closing 12 positions and reducing 46 holdings. Its most notable exit was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $21.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Crestwood Advisors Group opened a new position in iShares Biotechnology ETF worth $10.3M.
- Crestwood Advisors Group's largest Q2 2016 buy was iShares Biotechnology ETF: 120,432 shares worth $10.3M.
- Crestwood Advisors Group added most to iShares Core MSCI EAFE ETF in Q2 2016, an estimated $2.92M increase.
- Crestwood Advisors Group's biggest Q2 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $5.6M.
- Crestwood Advisors Group fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2016, selling an estimated $21.5M.
- Crestwood Advisors Group's ten largest holdings make up 32% of its $809M portfolio in Q2 2016.
- Crestwood Advisors Group opened 7 new positions and closed 12 in Q2 2016.
- Crestwood Advisors Group's portfolio value fell 4.5% quarter-over-quarter to $809M.
Based on Crestwood Advisors Group's 13F filing for Q2 2016, filed 15 Aug 2016.